CII vs EMO

CII exhibits a stable financial profile with a Piotroski F-Score of 6/9 and no debt, indicating solid operational health. The asset is severely undervalued, trading at $23.77 despite a Graham Number of $50.85 and an intrinsic value estimate of $149.86. With an exceptionally low P/E of 4.68 and a strong dividend yield of 7.12%, the fund offers significant value and income potential. While the technical trend score is listed as bearish, the actual 1-year price performance of +55.4% suggests strong underlying momentum.

The deterministic health profile is severely compromised, headlined by a Piotroski F-Score of 1/9, indicating critical fundamental weakness. While the fund has delivered exceptional long-term price appreciation (+273% over 5 years) and maintains an attractive dividend yield of 8.81%, these are overshadowed by a 0/100 technical trend and poor insider sentiment. The lack of traditional valuation metrics is typical for a Closed-End Fund, but the combination of a failing health score and bearish momentum suggests a high-risk entry point.